Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Natpara
Pharma
J&J-Legend, Takeda, Merck and more—Fierce Pharma Asia
J&J and Legend double down on CAR-T production. Takeda stops making Natpara. Merck builds new facilities in Singapore.
Angus Liu
Oct 7, 2022 10:50am
Takeda is calling it quits on Natpara's US commercial return
Oct 4, 2022 2:35pm
Trade secret suit, Lilly-Innovent, Aurobindo—Fierce Pharma Asia
Mar 25, 2022 9:00am
Takeda's Japan plant reemerges from FDA warning letter
Oct 28, 2021 10:05am
Takeda-CSL, Daiichi, Legend-J&J and more—Fierce Pharma Asia
Apr 9, 2021 10:25am
Takeda eyes March 2022 for Natpara's return to market
Apr 5, 2021 2:53pm
